TRAVERSA SERGIO bought RLMD

December 15, 2025 · Form 4 insider transaction

TRAVERSA SERGIO bought 27,500 shares of Relmada Therapeutics, Inc. at $4.12 per share, a transaction worth $113.3K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Acquired (buy-side)
Shares
27,500
Price
$4.12
Total value
$113.3K
Role
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateDecember 15, 2025
Filing dateDecember 16, 2025
Shares owned after1,300,000
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.; Purchase prices range from $4.10 to $4.12 per share, inclusive.

View the original Form 4 on SEC EDGAR